Pharmaceuticals news FT.com

GSK is emerging from its long convalescence

Drugmaker pins hopes on launch of new medicines but key point is to avoid re-traumatising investors

Feb 9, 2025 - 22:26
 0
GSK is emerging from its long convalescence
Drugmaker pins hopes on launch of new medicines but key point is to avoid re-traumatising investors
Read More

Tags:

Previous Article

The inside story of Britain’s failure to clinch £450mn AstraZeneca deal

Next Article

Eli Lilly expects to beat profit forecasts on obesity drug demand

Related Posts

The copycat brands that are replacing Ozempic in Russia

The copycat brands that are replacing Ozempic in Russia

Feb 19, 2025  0

Trade war could put the frown back on Botox users’ faces

Trade war could put the frown back on Botox users’ faces

Apr 13, 2025  0

Pfizer CEO ‘disappointed’ by Kennedy’s refusal to rebut claims on jab risks

Pfizer CEO ‘disappointed’ by Kennedy’s refusal to rebut...

Feb 9, 2025  0